TLK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.072380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.726200E-01
Normal-vs-Stage2
1.276790E-01
Normal-vs-Stage3
8.566300E-02
Normal-vs-Stage4
5.004400E-01
Stage1-vs-Stage2
7.242200E-01
Stage1-vs-Stage3
8.051900E-02
Stage1-vs-Stage4
3.369200E-01
Stage2-vs-Stage3
1.124560E-01
Stage2-vs-Stage4
5.957800E-01
Stage3-vs-Stage4
5.399800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.234000E-02
Normal-vs-AfricanAmerican
6.134600E-01
Normal-vs-Asian
2.440000E-01
Caucasian-vs-AfricanAmerican
2.528000E-01
Caucasian-vs-Asian
5.913200E-01
AfricanAmerican-vs-Asian
3.626400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.462960E-01
Normal-vs-Female
8.655600E-02
Male-vs-Female
5.020000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.691800E-01
Normal-vs-Age(41-60Yrs)
2.913800E-01
Normal-vs-Age(61-80Yrs)
7.777800E-02
Normal-vs-Age(81-100Yrs)
3.265400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.187800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.660000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.069200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.459820E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.650500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.497000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.893900E-02
Normal-vs-Daily Drinker
4.792100E-02
Normal-vs-Weekly Drinker
1.266610E-01
Normal-vs-Occasional Drinker
3.528800E-01
Normal-vs-Social Drinker
1.388990E-01
Non Drinker-vs-Daily Drinker
5.607000E-01
Non Drinker-vs-Weekly Drinker
7.076200E-01
Non Drinker-vs-Occasional Drinker
7.606100E-02
Non Drinker-vs-Social Drinker
7.823000E-01
Daily Drinker-vs-Weekly Drinker
9.272200E-01
Daily Drinker-vs-Occasional Drinker
1.994100E-02
Daily Drinker-vs-Social Drinker
4.225000E-01
Weekly Drinker-vs-Occasional Drinker
7.285700E-02
Weekly Drinker-vs-Social Drinker
5.747200E-01
Occasional Drinker-vs-Social Drinker
1.713840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.980000E-02
Normal-vs-Grade 2
5.575700E-03
Normal-vs-Grade 3
4.338100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.724400E-01
Grade 1-vs-Grade 3
2.805000E-01
Grade 1-vs-Grade 4
3.980000E-02
Grade 2-vs-Grade 3
5.251000E-01
Grade 2-vs-Grade 4
5.575700E-03
Grade 3-vs-Grade 4
4.338100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.239900E-02
Normal-vs-NonDiabetic
7.620300E-02
Diabetic-vs-NonDiabetic
5.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.204200E-02
Normal-vs-NoPancreatitis
8.262500E-02
Pancreatitis-vs-NoPancreatitis
3.569200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.019180E-01
Normal-vs-N1
1.277760E-01
N0-vs-N1
6.343600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.474400E-01
Normal-vs-TP53-NonMutant
3.357600E-01
TP53-Mutant-vs-TP53-NonMutant
2.687000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
